Coquí Pharma completes design of medial isotope facility

Coquí Pharma completes design of medial isotope facility
Coquí RadioPharmaceuticals Corp has completed the schematic design of its $330 million medical isotope production facility to be built in Alachua, Florida. Coquí Pharma will soon enter the detailed design phase as it readies to submit its construction licence application to the Nuclear Regulatory Commission by the end of 2015.

The Puerto Rican company, based in Coral Gables, aims to become the first US commercial supplier of the lifesaving radioisotope Molybdenum-99 (Mo-99), which is used in 20 million procedures each year in the USA.
Mo-99 is used in medical equipment to generate Technetium-99m (Tc-99m), the most widely used isotope in nuclear medicine. Mo-99 has a half-life of only 66 hours, meaning that supplies need to be constantly replenished.
Canada's National Research Universal reactor, built at Chalk River in 1957, produces 40% of world supply of Mo-99. It is due to be shut down in March 2018.

http://www.world-nuclear-news.org/C-Coqui-Pharma-completes-design-of-medial-isotope-facility-09041502.html